AURORAX-0093A: Glycosaminoglycan Profiling for Prognostication of Muscle-invasive Bladder Cancer - a Pilot Study

NCT05028660 · clinicaltrials.gov ↗

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Muscle-Invasive Bladder Carcinoma

Interventions

DIAGNOSTIC_TEST: GAG score

Sponsor

Elypta

Collaborators

[object Object]